MCL1 and breast cancer: MCL1 mRNA is higher in Basal (including Claudin-low (CL)) breast cancers relative to other subtypes (Fig. 2a, b) and we reasoned that MCL-1 may have differential prognostic significance in certain subtypes of breast cancer.